Tiger Aesthetics invests in GenesisTissue
Tiger Aesthetics Medical, a division of Tiger Biosciences based in Conshohocken, Pennsylvania, has announced a strategic investment in GenesisTissue Inc, an early-stage biotechnology company developing personalized 3D bioprinting technologies for breast reconstruction and cosmetic surgery. The startup is creating solutions for both lumpectomy and mastectomy reconstruction, as well as aesthetic applications. This collaboration extends Tiger Biosciences’ regenerative medicine initiatives and follows the 2025 launch of alloClae, a ready-to-use structural adipose tissue product for body contouring.